AEM.TO (AEM.TO)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 9/9, Altman Z 9.5 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of this entity display robust capital efficiency, evidenced by a Return on Invested Capital significantly exceeding the cost of equity at an 8.0% spread. This high-quality profile is further corroborated by a pristine Piotroski F-Score of 9/9 and an Altman Z-Score of 9.5, which collectively signal exceptional financial strength and minimal distress risk. The DuPont decomposition reveals that the 18.0% Return on Equity is primarily driven by superior pricing power rather than operational leverage or asset intensity; specifically, a net margin of 37.5% outweighs modest asset turnover at 0.35x, while moderate equity multipliers suggest the firm does not rely heavily on debt financing to generate returns. Additionally, the negative Beneish M-Score of -2.69 indicates low probability of earnings manipulation, reinforcing the integrity of these high-margin figures against a backdrop of accelerating revenue growth exceeding 40% year-over-year.
Valuation metrics present a divergence between historical multiples and intrinsic value estimates derived from discounted cash flow modeling. The current price-to-earnings ratio of 21.8x requires contextualization against sector peers, as the provided data lacks comparative benchmarks to determine if this premium is justified by growth expectations or represents overvaluation. However, the DCF model assigns a fair value of $114 per share, implying specific assumptions regarding long-term sustainable growth rates and terminal values that may differ from current market sentiment. If the prevailing P/E multiple embeds growth projections higher than those utilized in the DCF calculation, the stock could be trading at an elevated premium relative to its intrinsic worth; conversely, if market expectations are muted despite strong fundamentals, the current pricing might offer a margin of safety approaching the calculated fair value.
The convergence of aggressive revenue expansion and flawless fundamental health scores suggests the company is navigating a favorable risk/reward landscape, though the high valuation multiple inherently increases sensitivity to any deterioration in margins or growth deceleration. The absence of sector-specific data limits a precise assessment of relative attractiveness compared to industry peers, but the internal consistency between profitability drivers and capital allocation efficiency points to a business model capable of sustaining returns above its cost of capital under current operating conditions.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.6% | 8.6% | 10.6% |
|---|---|---|---|
| 2% | $141 | $101 | $80 |
| 3% | $171 | $114 | $87 |
| 4% | $224 | $132 | $95 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.6%, terminal growth 3%. Fair value $114 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in AEM.TO to visualize passive redemption contagion across ETFs and collateral stocks.
If AEM.TO (AEM.TO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Royal Bank of Canada (RY) as the most exposed collateral stock, sharing 1 ETFs with AEM.TO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
AEM.TO Ownership Dynamics
ETFs with Highest AEM.TO Exposure
Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
AEM.TO Capital Efficiency
How efficiently does AEM.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
AEM.TO converts 51% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 8.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare AEM.TO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.